Defining the Potential for Disease Modification in Atopic Dermatitis

Area of Science:

• Dermatology
• Immunology
• Pathophysiology

Background:

• Atopic dermatitis is a prevalent inflammatory skin condition with significant patient burden.
• Current treatments primarily manage symptoms, not the disease course.
• A clear definition of disease modification in AD is lacking.

Purpose of the Study:

• To review the concept of disease modification in atopic dermatitis.
• To explore dimensions of disease modification including pathophysiology, control, comorbidities, and biomarkers.
• To emphasize the role of early intervention in altering AD progression.

Main Methods:

• Literature review on disease modification in atopic dermatitis.
• Analysis of underlying pathophysiology and disease control.
• Examination of atopic and nonatopic comorbidities.
• Discussion of subclinical biomarkers and early therapeutic strategies.

Main Results:

• Emerging therapies may modify atopic dermatitis (AD) course, enabling remission and preventing comorbidities.
• Disease modification in AD requires consensus on its definition and scope.
• Identifying long-term effective therapies is crucial for reducing the global health burden of atopic diseases.

Conclusions:

• Defining and achieving disease modification in atopic dermatitis is a key therapeutic goal.
• A comprehensive approach considering pathophysiology, comorbidities, and biomarkers is needed.
• Early interventions hold promise for altering the long-term trajectory of atopic dermatitis.